GlassScriptPhysician profile
Robert K Salley
NPI 1790888113
$5,919.31
in general payments reported to CMS, 2019-2025
13 companies · $83.85 in 2025
The $83.85 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,294 · 2020: $254 · 2021: $1,095 · 2022: $440 · 2023: $521 · 2024: $232 · 2025: $83.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $836.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $836.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,928.03 | 2019-2020 | |
| Atricure, INC. | $1,888.95 | 2019-2023 | |
| Artivion, INC. | $958.75 | 2019 | |
| Medtronic, INC. | $510.73 | 2021-2024 | Penditure, Avalus |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $175.33 | 2024-2025 | |
| Baxter Healthcare | $149.03 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $104.91 | 2019 | |
| Cardiofocus, INC. | $91.10 | 2019 | |
| Medistim USA, INC. | $50.08 | 2019 | |
| Ethicon US, LLC | $28.38 | 2021-2023 | Mega Soft |
| Getinge USA Sales, LLC | $19.59 | 2023 | Vasoview Hemopro 2 |
| Angiodynamics, INC. | $14.43 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Salley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.